MerLion Pharmaceuticals Completes Growth Financing Round
MerLion Pharmaceuticals Completes Growth Financing Round 05/18/2021 | 03:30am EDT Send by mail : Message : TM Berlin, (18/05/2021) - MerLion Pharmaceuticals GmbH (MerLion), a biopharmaceutical company focused on research and development of novel antibiotics for the treatment of serious bacterial infections, today announced the successful completion of a growth financing round raised via a private placement to European strategic investors. The funds raised will primarily be used to finance the production and market launch of MerLion’s US FDA and Health Canada approved drug Xtoro TM, an otic...